199 related articles for article (PubMed ID: 29271013)
1. Do needle and syringe programs reduce risky behaviours among people who inject drugs in Kermanshah City, Iran? A coarsened exact matching approach.
Noroozi M; Marshall BDL; Noroozi A; Armoon B; Sharifi H; Farhoudian A; Ghiasvand H; Vameghi M; Rezaei O; Sayadnasiri M; Pouya RH
Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S303-S308. PubMed ID: 29271013
[TBL] [Abstract][Full Text] [Related]
2. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran.
Nazari SS; Noroozi M; Soori H; Noroozi A; Mehrabi Y; Hajebi A; Sharifi H; Higgs P; Mirzazadeh A
Int J Drug Policy; 2016 Jan; 27():127-31. PubMed ID: 26764125
[TBL] [Abstract][Full Text] [Related]
3. Needle and Syringe Programs and HIV-Related Risk Behaviors Among Men Who Inject Drugs: A Multilevel Analysis of Two Cities in Iran.
Noroozi M; Noroozi A; Sharifi H; Harouni GG; Marshall BDL; Ghisvand H; Qorbani M; Armoon B
Int J Behav Med; 2019 Feb; 26(1):50-58. PubMed ID: 30460445
[TBL] [Abstract][Full Text] [Related]
4. Impact of HIV Status Notification on Risk Behaviors among Men Who Inject Drugs in Kermanshah, West of Iran.
Noroozi A; Mirzazadeh A; Farhoudian A; Hajebi A; Khankeh HR; Higgs P; Sharifi H; Armoon B; Noroozi M
J Res Health Sci; 2016; 16(3):116-121. PubMed ID: 27840338
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of pharmacy-based needle/syringe exchange programme for people who inject drugs: a systematic review and meta-analysis.
Sawangjit R; Khan TM; Chaiyakunapruk N
Addiction; 2017 Feb; 112(2):236-247. PubMed ID: 27566970
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors for injection site skin infections among people who inject drugs (PWID) in Tehran.
Noroozi M; Armoon B; Ghisvand H; Noroozi A; Karimy M; Bazrafshan MR; Marshall BDL; Dieji B
J Cosmet Dermatol; 2019 Feb; 18(1):258-262. PubMed ID: 29781249
[TBL] [Abstract][Full Text] [Related]
7. Client-Level Coverage of Needle and Syringe Program and High-Risk Injection Behaviors: A Case Study of People Who Inject Drugs in Kermanshah, Iran.
Noroozi M; Mirzazadeh A; Noroozi A; Mehrabi Y; Hajebi A; Zamani S; Sharifi H; Higgs P; Soori H
Addict Health; 2015; 7(3-4):164-73. PubMed ID: 26885353
[TBL] [Abstract][Full Text] [Related]
8. Effect of Alcohol Use on Injection and Sexual Behavior among People Who Inject Drugs in Tehran, Iran: A Coarsened Exact Matching Approach.
Noroozi M; Marshall BDL; Noroozi A; Armoon B; Sharifi H; Qorbani M; Abbasi M; Bazrafshan MR
J Res Health Sci; 2018 May; 18(2):e00416. PubMed ID: 29784897
[TBL] [Abstract][Full Text] [Related]
9. Syringe Stockpiling by Persons Who Inject Drugs: An Evaluation of Current Measures for Needle and Syringe Program Coverage.
McCormack AR; Aitken CK; Burns LA; Cogger S; Dietze PM
Am J Epidemiol; 2016 May; 183(9):852-60. PubMed ID: 27049004
[TBL] [Abstract][Full Text] [Related]
10. Perceived discrimination and injecting risk among people who inject drugs attending Needle and Syringe Programmes in Sydney, Australia.
Wilson H; Brener L; Mao L; Treloar C
Drug Alcohol Depend; 2014 Nov; 144():274-8. PubMed ID: 25236889
[TBL] [Abstract][Full Text] [Related]
11. Increasing awareness about HIV prevention among young people who initiated injection drug use in a Canadian setting, 1988-2014.
Bahji A; Wood E; Ahamad K; Dong H; DeBeck K; Milloy MJ; Kerr T; Hayashi K
Int J Drug Policy; 2015 Dec; 26(12):1258-64. PubMed ID: 26514080
[TBL] [Abstract][Full Text] [Related]
12. Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia.
Otiashvili D; Kirtadze I; Vardanashvili I; Tabatadze M; Ober AJ
Harm Reduct J; 2019 Mar; 16(1):21. PubMed ID: 30898120
[TBL] [Abstract][Full Text] [Related]
13. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis.
Platt L; Minozzi S; Reed J; Vickerman P; Hagan H; French C; Jordan A; Degenhardt L; Hope V; Hutchinson S; Maher L; Palmateer N; Taylor A; Bruneau J; Hickman M
Addiction; 2018 Mar; 113(3):545-563. PubMed ID: 28891267
[TBL] [Abstract][Full Text] [Related]
14. Decomposition of Economic Inequality in Needle and Syringe Programs Utilization to its Determinants among Men Who Inject Drugs in Tehran using Blinder-Oaxaca Decomposition Method.
Noroozi M; Rahimi E; Ghisvand H; Qorbani M; Sharifi H; Noroozi A; Farhoudian A; Marshall BDL; Jorjoran Shoshtari Z; Karimi SE; Rezaei O; Armoon B
Subst Use Misuse; 2018 Jun; 53(7):1170-1176. PubMed ID: 29166171
[TBL] [Abstract][Full Text] [Related]
15. Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019-2020.
Tookes HE; Bartholomew TS; Sugar SES; Plesons MD; Bluthenthal RN; Wenger LD; Patel SV; Kral AH; Lambdin BH
Int J Drug Policy; 2024 Jan; 123():104289. PubMed ID: 38071932
[TBL] [Abstract][Full Text] [Related]
16. Individual-level syringe coverage among Needle and Syringe Program attendees in Australia.
Iversen J; Topp L; Wand H; Maher L
Drug Alcohol Depend; 2012 May; 122(3):195-200. PubMed ID: 22071120
[TBL] [Abstract][Full Text] [Related]
17. Health risk and health seeking behaviours among people who inject performance and image enhancing drugs who access needle syringe programs in Australia.
Van de Ven K; Maher L; Wand H; Memedovic S; Jackson E; Iversen J
Drug Alcohol Rev; 2018 Nov; 37(7):837-846. PubMed ID: 29968372
[TBL] [Abstract][Full Text] [Related]
18. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis.
Aspinall EJ; Nambiar D; Goldberg DJ; Hickman M; Weir A; Van Velzen E; Palmateer N; Doyle JS; Hellard ME; Hutchinson SJ
Int J Epidemiol; 2014 Feb; 43(1):235-48. PubMed ID: 24374889
[TBL] [Abstract][Full Text] [Related]
19. High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review.
Des Jarlais DC; Feelemyer JP; Modi SN; Abdul-Quader A; Hagan H
BMC Public Health; 2013 Jan; 13():53. PubMed ID: 23332005
[TBL] [Abstract][Full Text] [Related]
20. Analysis of time of drug use according to needle and syringe program operating hours in Melbourne, Australia: Effects on individual-level needle and syringe coverage.
O'Keefe D; Aitken C; Scott N; Dietze P
Drug Alcohol Depend; 2018 Oct; 191():259-265. PubMed ID: 30153607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
